지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2022.2
- 수록면
- 38 - 52 (15page)
이용수
초록· 키워드
오류제보하기
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide, and non-alcoholic steatohepatitis (NASH), a subtype of NAFLD, can progress to cirrhosis, hepatocellular carcinoma, and death. Nevertheless, the current treatment for NAFLD/NASH is limited to lifestyle modifications, and no drugs are currently officially approved as treatments for NASH. Many global pharmaceutical companies are pursuing the development of medications for the treatment of NASH, and results from phase 2 and 3 clinical trials have been published in recent years. Here, we review data from these recent clinical trials and reports on the efficacy of newly developed antidiabetic drugs in NASH treatment.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management
Clinical and Molecular Hepatology
2023 .02
-
Pharmacological advances in the treatment of nonalcoholic fatty liver diseases : focused on global results of randomized controlled trials
Clinical and Molecular Hepatology
2023 .02
-
Pharmacologic therapy for nonalcoholic steatohepatitis focusing on pathophysiology
Journal of Yeungnam Medical Science
2019 .01
-
비알코올성 지방간 질환의 진단적 평가
대한내과학회지
2020 .10
-
Recent research trends and updates on nonalcoholic fatty liver disease
Clinical and Molecular Hepatology
2019 .01
-
Pharmacologic therapy for nonalcoholic steatohepatitis focusing on pathophysiology
영남의대학술지
2019 .01
-
Genetics in non-alcoholic fatty liver disease: The role of risk alleles through the lens of immune response
Clinical and Molecular Hepatology
2023 .02
-
Screening strategies for non-alcoholic fatty liver disease: a holistic approach is needed
Clinical and Molecular Hepatology
2023 .04
-
Old and new classes of glucose-lowering agents as treatments for non-alcoholic fatty liver disease: A narrative review
Clinical and Molecular Hepatology
2022 .10
-
Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease
Clinical and Molecular Hepatology
2020 .01
-
Nonalcoholic Fatty Liver Disease: A Drug Revolution Is Coming
Diabetes and Metabolism Journal
2020 .01
-
Non-alcoholic fatty liver disease: Definition and subtypes
Clinical and Molecular Hepatology
2023 .02
-
Surveillance of the progression and assessment of treatment endpoints for nonalcoholic steatohepatitis
Clinical and Molecular Hepatology
2023 .02
-
The Immune Landscape in Nonalcoholic Steatohepatitis
Immune Network
2016 .06
-
Liver Transplantation for HCC in NASH/NAFLD Patients: Outcomes and Complications
대한외과학회 학술대회 초록집
2021 .11
-
STAMP2 expression in non-alcoholic fatty liver disease, in vivo
한국실험동물학회 학술발표대회 논문집
2019 .01
-
Atorvastatin on Treatment of Nonalcoholic Fatty Liver Disease Patients
전남의대학술지
2024 .01
-
Recent advances in nonalcoholic fatty liver disease metabolomics
Clinical and Molecular Hepatology
2021 .10
-
Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis
Clinical and Molecular Hepatology
2021 .01
-
Hepatocellular Carcinoma Surveillance and Screening in NASH/NAFLD and Metabolic Syndrome Patients: Western vs. Korean Experiences
대한외과학회 학술대회 초록집
2021 .11
이 논문의 저자 정보
최근 본 자료
댓글(0)
0